We are live on
!
Find out more
SC
Stephens Consulting Portfolio holdings
AUM
$309M
1-Year Est. Return
14.46%
This Fund
S&P 500
This Quarter
Est. Return
+9.59%
1 Year Est. Return
+14.46%
3 Year Est. Return
+50.05%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$295M
AUM Growth
+$49M
(+20%)
Cap. Flow
+$24.4M
Cap. Flow
% of AUM
8.27%
Top 10 Holdings %
Top 10 Hldgs %
70.85%
Holding
513
New
11
Increased
71
Reduced
72
Closed
28
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares National Muni Bond ETF
MUB
|
+$4.56M |
| 2 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$3.67M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$2.81M |
| 4 |
Raymond James Financial
RJF
|
+$2.73M |
| 5 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$2.24M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$3.76M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$703K |
| 3 |
iShares ESG Aware MSCI USA Small-Cap ETF
ESML
|
+$134K |
| 4 |
Vanguard High Dividend Yield ETF
VYM
|
+$119K |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$82.3K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 86.17% |
| 2 | Financials | 4.41% |
| 3 | Technology | 3.11% |
| 4 | Consumer Staples | 1.95% |
| 5 | Healthcare | 1.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Organon & Co
OGN
$3.62B
| – | – |
-5
| Closed | -$87 |
|
|
502
Regeneron Pharmaceuticals
REGN
$85.2B
| – | – |
-100
| Closed | -$82.3K |
|
|
THQ
503
abrdn Healthcare Opportunities Fund
THQ
$819M
| – | – |
-2,727
| Closed | -$46.3K |
|
504
iShares TIPS Bond ETF
TIP
$15B
| – | – |
-776
| Closed | -$80.5K |
|
505
Under Armour
UAA
$2.26B
| – | – |
-330
| Closed | -$2.26K |
|
506
UBS Group
UBS
$170B
| – | – |
-3
| Closed | -$74 |
|
|
RVNC
507
DELISTED
Revance Therapeutics, Inc.
RVNC
| – | – |
-500
| Closed | -$5.74K |
|
|
EGIO
508
DELISTED
Edgio, Inc. Common Stock
EGIO
| – | – |
-10
| Closed | -$341 |
|
|
IBDO
509
DELISTED
iShares iBonds Dec 2023 Term Corporate ETF
IBDO
| – | – |
-189
| Closed | -$4.79K |
|
|
IBTD
510
DELISTED
iShares iBonds Dec 2023 Term Treasury ETF
IBTD
| – | – |
-306
| Closed | -$7.59K |
|
|
IBML
511
DELISTED
iShares iBonds Dec 2023 Term Muni Bond ETF
IBML
| – | – |
-313
| Closed | -$7.99K |
|
|
HEP
512
DELISTED
Holly Energy Partners, L.P.
HEP
| – | – |
-200
| Closed | -$4.39K |
|
|
RAD
513
DELISTED
Rite Aid Corporation
RAD
| – | – |
-82
| Closed | -$37 |
|
Similar funds
PWM
TPW
PPH
OFS
YCG
CP
SCM
LODC
Stephens Consulting's Q4 2023 Portfolio in Review
As of Q4 2023, Stephens Consulting held 513 positions worth $295M, up 20% from $246M the previous quarter. Its ten largest holdings account for 71% of the portfolio.
Stephens Consulting deployed $24.4M of net new capital in Q4 2023, opening 11 new positions and adding to 71 existing holdings. Its largest new stake was Columbia Banking Systems: 5,635 shares worth $150K.
By sector, the portfolio is most concentrated in Miscellaneous at 86% of assets, down from 87% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Vanguard Short-Term Bond ETF, an estimated $3.76M trimmed.
- Stephens Consulting's largest Q4 2023 buy was Columbia Banking Systems: 5,635 shares worth $150K.
- Stephens Consulting added most to iShares National Muni Bond ETF in Q4 2023, an estimated $4.56M increase.
- Stephens Consulting's biggest Q4 2023 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $3.76M.
- Stephens Consulting fully exited Regeneron Pharmaceuticals in Q4 2023, selling an estimated $82.3K.
- Stephens Consulting's ten largest holdings make up 71% of its $295M portfolio in Q4 2023.
- Stephens Consulting opened 11 new positions and closed 28 in Q4 2023.
- Stephens Consulting's portfolio value rose 20% quarter-over-quarter to $295M.
Based on Stephens Consulting's 13F filing for Q4 2023, filed 1 Feb 2024.